We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panels Support Apadaz Approval, Shoot Down Abuse-Deterrent Label
FDA Panels Support Apadaz Approval, Shoot Down Abuse-Deterrent Label
Two FDA advisory committees recommended the FDA approve KemPharm’s opioid pill Apadaz, even though they rejected an abuse-deterrent label for the candidate.